Clear Creek Financial Management’s GSK GSK Stock Holding History

Clear Creek Financial Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$274K	Buy	5,225 +272	+5%	+$14.4K	0.02%	548
2026 Q1	$273K	Buy	4,953 +1	+0%	+$54	0.02%	520
2025 Q4	$243K	Buy	+4,952	New	+$231K	0.02%	522

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clear Creek Financial Management's GSK Position: Q2 2026 in Review

Clear Creek Financial Management increased its GSK (GSK) stake by 5.5% in Q2 2026, buying an estimated $14.4K and bringing the position to 5,225 shares worth $274K. The position accounts for 0.02% of the portfolio, ranked #548.

Clear Creek Financial Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Clear Creek Financial Management held 5,225 shares of GSK worth $274K as of Q2 2026.
Clear Creek Financial Management bought 272 GSK shares in Q2 2026, an estimated $14.4K.
GSK made up 0.02% of Clear Creek Financial Management's portfolio in Q2 2026, its #548 holding.
Clear Creek Financial Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.